SMAD4 and pancreatic adenocarcinoma: Nevertheless, the three genes identified in PAAD for which IHC data was available (PTPRN, SCG5, KRT14) indicated that an important switch exists between ERBB2 and SMAD4 expression i.e. the oncogene and tumor suppressor, respectively80,81.